PLANEGG, Germany–Biomax Informatics AG announces that their longtime client, Royal DSM N.V., has signed a multi-year license for the Biomax “semantic search” technology to implement their new enterprise knowledge platform for fast, simple and comprehensive knowledge discovery. The Biomax™ semantic search technology provides an extensible framework that automatically maintains a growing and evolving semantic network. […]
BC Platforms, a world leader in genomic data management and analysis solutions, today announced it has partnered with Google Cloud to deliver its highly scalable integrated genomics and clinical data solutions to hospital and industry partners worldwide. In addition to storage, archiving and calculation capacity, Google Cloud genomics and AI tools, including DeepVariant, will be […]
Edico’s DRAGEN® Bio-IT Platform Delivers Faster, Streamlined Output for Next-Generation Sequencing SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) today announced that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing (NGS). Edico Genome’s DRAGEN® Bio-IT Platform (DRAGEN) uses field programmable gate array (FPGA) technology in conjunction with proprietary software algorithms to reduce both data […]
BC Platforms, a world leader in genomic data management and analysis solutions, today announces that it has partnered with Sentieon to integrate Sentieon’s award winning NGS data processing software into BC Platform’s highly scalable integrated genomics and clinical data solutions. This combination of technologies will provide an integrated system enabling highly accurate sample by sample […]
DILIsym Services, Inc., a Simulations Plus company (NASDAQ: SLP) and a leading provider of simulation and modeling software for pharmaceutical safety, today announced that the U.S. Food and Drug Administration has secured an annual government license for its flagship QSP (quantitative systems pharmacology) modeling software, DILIsym®. DILIsym is the product of an ongoing public-private partnership (the […]
San Diego, CA – OnRamp Bioinformatics, Inc., a genomics company providing the premier scientist-focused data analysis platform, and Advaita BioInformatics, a leader in personalized medicine and interpretation of Next-Gen Sequencing data, announced they are partnering to provide a comprehensive research experience from sample to interpretation with a seamless handoff between systems. OnRamp.Bio’s flagship product, ROSALIND™, enables […]
Our CEO Anthony Finbow has been appointed Vice Chairman of the newly formed BIA (UK BioIndustry Association) Genomics Advisory Committee. The committee has been established to support the strategic objective that the UK starts, scales and builds world leading genomic businesses. The Committee will act as a leadership platform for sharing and discussing issues of common […]
SAN CARLOS, Calif. — Protein Metrics Inc., a leading provider of mass spectrometry software for protein characterization, today introduced the Byos™ platform, which automates biotherapeutic characterization workflows with just one click. “Byos enabled our lab to characterize and report on sets of candidates in parallel, reducing analytical time for clone selection by 20-30%, and substantially improving […]
LAUSANNE, Switzerlan: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today that its technology for clinical genomics, SOPHiA artificial intelligence, has reached a key milestone in helping better diagnose 200’000 patients. Adopted by over 430 hospitals across 60 countries, SOPHiA AI has proven to be a robust and standardized decision support technology for clinicians. SOPHiA is […]
We are delighted to introduce a new version of Qlucore Omics Explorer – 3.4, an exciting new release with a wide range of productive tools to enhance your data analysis, making it easier and faster to gain new research insights. Qlucore Omics Explorer 3.4 includes the following news Single cell RNA-seq support including a t-SNE […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
